MRS. RAQUEL ORTELLI MORROW APRN, FNP-C
Prescription History 1316638539
Nurse Practitioner - Family in Lake Charles, LA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. RAQUEL ORTELLI MORROW APRN, FNP-C, an active Family specialist practicing in Lake Charles, LA. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 51 documented patient claims. Among these therapy options, the most frequently utilized medication is Nitrofurantoin Mono-Macro, which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other LA PrescribersVs. LA Avg |
|---|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $11.39▼ below LA avg | ▼ Less than typical |
About Nitrofurantoin Mono-Macro: This medication is an antibiotic used to treat bladder infections (acute cystitis). Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses). In 2024, this provider wrote 14 Medicare prescriptions for Nitrofurantoin Mono-Macro, about half the volume of the typical Louisiana prescriber of this medication (30.5). Medicare paid an average of $11.39 per fill, versus $18.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 14 30-Day Fills standardized to 30-day supplies 68 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 13 | $5.68▼ below LA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 13 Medicare prescriptions for Gabapentin, about 11% of the volume of the typical Louisiana prescriber of this medication (122.2). Medicare paid an average of $5.68 per fill, versus $12.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 13 30-Day Fills standardized to 30-day supplies 362 Days of Medication total across all patients in 2024 | |||
| LantusInsulin Glargine,hum.Rec.Anlog | 13 | $73.09▼ below LA avg | ▼ Less than typical |
About Lantus: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2024, this provider wrote 13 Medicare prescriptions for Lantus, about half the volume of the typical Louisiana prescriber of this medication (25.7). Medicare paid an average of $73.09 per fill, versus $104.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 13 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2024 | |||
| NystopNystatin | 11 | $30.57 | ▼ Less than typical |
About Nystop: Nystatin is used to treat fungal skin infections. Show more ▾ Nystatin is an antifungal that works by stopping the growth of fungus. Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. In 2024, this provider wrote 11 Medicare prescriptions for Nystop, about half the volume of the typical Louisiana prescriber of this medication (19.7). Medicare paid an average of $30.57 per fill, versus $29.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 154 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MRS. RAQUEL ORTELLI MORROW APRN, FNP-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Lake Charles, LA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among LA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
